9 Meters Biopharma, Inc.
Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors

Last updated:

Abstract:

The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy. The methods comprise administering larazotide or a derivative thereof such as (d)-larazotide to a subject in need, including subjects undergoing checkpoint inhibitor therapy, and subjects scheduled to undergo immune checkpoint inhibitor therapy.

Status:
Grant
Type:

Utility

Filling date:

23 Apr 2021

Issue date:

22 Mar 2022